Perspective Therapeutics (CATX) Q4 2024 Annual Earnings
CATX·Reported March 26, 2025·After market close
Perspective Therapeutics reported Q4 2024 revenue of $234.0K, missed analyst consensus of $277.3K by $43.3K. Diluted EPS came in at $-0.25, beat the $-0.26 consensus by $0.01.
Revenue
$234.0Kmissed by $43.3K
Consensus: $277.3KDiluted EPS
$-0.25beat by $0.01
Consensus: $-0.26
Financial Snapshot
Trailing eight quarters through Q4 2024
Q4 2024 Earnings FAQ
Common questions about Perspective Therapeutics's Q4 2024 earnings report.
Perspective Therapeutics (CATX) reported Q4 2024 earnings on March 26, 2025 after market close.
Perspective Therapeutics reported revenue of $234.0K and diluted EPS of $-0.25 for Q4 2024.
Revenue missed the consensus estimate of $277.3K by $43.3K. EPS beat the consensus estimate of $-0.26 by $0.01.
You can read the 10-K periodic report (0000950170-25-045242) directly on SEC EDGAR. The filing index links above go to sec.gov.